{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:31:01Z","timestamp":1790692261808,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2021 Doctoral Fund project of Hunan Provincial People's Hospital","award":["BSJJ202120"],"award-info":[{"award-number":["BSJJ202120"]}]},{"name":"Fund project of Hunan Provincial Department of Finance","award":["2022CZT02"],"award-info":[{"award-number":["2022CZT02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11010-024-05004-1","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T16:01:21Z","timestamp":1716134481000},"page":"1063-1075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LncRNA CCAT1 knockdown suppresses tongue squamous cell carcinoma progression by inhibiting the ubiquitination of PHLPP2"],"prefix":"10.1007","volume":"480","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,19]]},"reference":[{"issue":"3","key":"5004_CR1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bjorl.2020.10.017","volume":"87","author":"BAC Melo","year":"2021","unstructured":"Melo BAC et al (2021) Human papillomavirus infection and oral squamous cell carcinoma - a systematic review. Braz J Otorhinolaryngol 87(3):346\u2013352","journal-title":"Braz J Otorhinolaryngol"},{"issue":"12","key":"5004_CR2","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/hed.26464","volume":"42","author":"NR Lenze","year":"2020","unstructured":"Lenze NR et al (2020) Age and risk of recurrence in oral tongue squamous cell carcinoma: systematic review. Head Neck 42(12):3755\u20133768","journal-title":"Head Neck"},{"issue":"5","key":"5004_CR3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4252\/wjsc.v15.i5.438","volume":"15","author":"P Joshi","year":"2023","unstructured":"Joshi P, Waghmare S (2023) Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: therapeutic implications and challenges. World J Stem Cells 15(5):438\u2013452","journal-title":"World J Stem Cells"},{"issue":"6","key":"5004_CR4","doi-asserted-by":"crossref","first-page":"C1611","DOI":"10.1152\/ajpcell.00098.2022","volume":"323","author":"K Matsuo","year":"2022","unstructured":"Matsuo K et al (2022) Squamous cell carcinoma of the tongue: subtypes and morphological features affecting prognosis. Am J Physiol Cell Physiol 323(6):C1611-c1623","journal-title":"Am J Physiol Cell Physiol"},{"key":"5004_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","volume":"1008","author":"J Jarroux","year":"2017","unstructured":"Jarroux J, Morillon A, Pinskaya M (2017) History, discovery, and Classification of lncRNAs. Adv Exp Med Biol 1008:1\u201346","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"5004_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.oooo.2019.08.011","volume":"129","author":"J Chen","year":"2020","unstructured":"Chen J et al (2020) Progress in the study of long noncoding RNA in tongue squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 129(1):51\u201358","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"5004_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00432-016-2268-3","volume":"143","author":"X Guo","year":"2017","unstructured":"Guo X, Hua Y (2017) CCAT1: an oncogenic long noncoding RNA in human cancers. J Cancer Res Clin Oncol 143(4):555\u2013562","journal-title":"J Cancer Res Clin Oncol"},{"issue":"21","key":"5004_CR8","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/15384101.2019.1662257","volume":"18","author":"GH Li","year":"2019","unstructured":"Li GH, Ma ZH, Wang X (2019) Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt\/\u03b2-catenin signaling pathway. Cell Cycle 18(21):2902\u20132913","journal-title":"Cell Cycle"},{"key":"5004_CR9","volume":"26","author":"M Sun","year":"2020","unstructured":"Sun M, Shen Z (2020) Knockdown of long non-coding RNA (lncRNA) colon cancer-associated transcript-1 (CCAT1) suppresses oral squamous cell carcinoma proliferation, invasion, and migration by inhibiting the discoidin domain receptor 2 (DDR2)\/ERK\/AKT Axis. Med Sci Monit 26:e920020","journal-title":"Med Sci Monit"},{"issue":"1","key":"5004_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5004_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","volume":"13","author":"X Zuo","year":"2020","unstructured":"Zuo X et al (2020) M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol 13(1):5","journal-title":"J Hematol Oncol"},{"key":"5004_CR12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2021.09.001","volume":"26","author":"D Rong","year":"2021","unstructured":"Rong D et al (2021) m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucleic Acids 26:637\u2013648","journal-title":"Mol Ther Nucleic Acids"},{"key":"5004_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110566","author":"Q Pan","year":"2023","unstructured":"Pan Q et al (2023) WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner. Genomics. https:\/\/doi.org\/10.1016\/j.ygeno.2023.110566","journal-title":"Genomics"},{"issue":"7","key":"5004_CR14","first-page":"3688","volume":"11","author":"A Paramasivam","year":"2021","unstructured":"Paramasivam A, George R, Priyadharsini JV (2021) Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. Am J Cancer Res 11(7):3688\u20133697","journal-title":"Am J Cancer Res"},{"issue":"1","key":"5004_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-018-0628-y","volume":"11","author":"X Huang","year":"2018","unstructured":"Huang X et al (2018) Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer. J Hematol Oncol 11(1):88","journal-title":"J Hematol Oncol"},{"issue":"9","key":"5004_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5483\/BMBRep.2021.54.9.095","volume":"54","author":"JH Cha","year":"2021","unstructured":"Cha JH et al (2021) Emerging roles of PHLPP phosphatases in metabolism. BMB Rep 54(9):451\u2013457","journal-title":"BMB Rep"},{"key":"5004_CR17","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.2147\/OTT.S221442","volume":"12","author":"S Chen","year":"2019","unstructured":"Chen S et al (2019) miR-762 promotes malignant development of head and neck squamous cell carcinoma by targeting PHLPP2 and FOXO4. Onco Targets Ther 12:11425\u201311436","journal-title":"Onco Targets Ther"},{"issue":"6","key":"5004_CR18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard J et al (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25(6):917\u2013931","journal-title":"Mol Cell"},{"issue":"1","key":"5004_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12263-022-00705-y","volume":"17","author":"M Peng","year":"2022","unstructured":"Peng M et al (2022) Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K\/AKT and Raf\/MEK\/ERK pathways in tongue squamous cell carcinoma. Genes Nutr 17(1):3","journal-title":"Genes Nutr"},{"issue":"4","key":"5004_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","volume":"42","author":"S Hatakeyama","year":"2017","unstructured":"Hatakeyama S (2017) TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci 42(4):297\u2013311","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"5004_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","volume":"13","author":"J Tantai","year":"2022","unstructured":"Tantai J et al (2022) TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis 13(3):285","journal-title":"Cell Death Dis"},{"issue":"9","key":"5004_CR22","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.ymthe.2021.04.036","volume":"29","author":"Z Chu","year":"2021","unstructured":"Chu Z et al (2021) FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect. Mol Ther 29(9):2737\u20132753","journal-title":"Mol Ther"},{"issue":"22","key":"5004_CR23","doi-asserted-by":"crossref","first-page":"10120","DOI":"10.7150\/thno.49147","volume":"10","author":"Y Hu","year":"2020","unstructured":"Hu Y et al (2020) A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Theranostics 10(22):10120\u201310140","journal-title":"Theranostics"},{"key":"5004_CR24","doi-asserted-by":"crossref","first-page":"1063636","DOI":"10.3389\/fonc.2023.1063636","volume":"13","author":"VY Cusenza","year":"2023","unstructured":"Cusenza VY et al (2023) The lncRNA epigenetics: the significance of m6A and m5C lncRNA modifications in cancer. Front Oncol 13:1063636","journal-title":"Front Oncol"},{"key":"5004_CR25","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen C et al (2021) m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance. Front Oncol 11:746789","journal-title":"Front Oncol"},{"key":"5004_CR26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2017.04.023","volume":"807","author":"CF Li","year":"2017","unstructured":"Li CF et al (2017) miR-938 promotes colorectal cancer cell proliferation via targeting tumor suppressor PHLPP2. Eur J Pharmacol 807:168\u2013173","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5004_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13046-017-0516-2","volume":"36","author":"L Ding","year":"2017","unstructured":"Ding L et al (2017) MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2. J Exp Clin Cancer Res 36(1):45","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"5004_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ygyno.2016.09.010","volume":"143","author":"Y Liao","year":"2016","unstructured":"Liao Y et al (2016) MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression. Gynecol Oncol 143(3):655\u2013663","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5004_CR29","first-page":"1568","volume":"153","author":"K Kim","year":"2017","unstructured":"Kim K et al (2017) Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway. Promotes Hepatic Steatosis Gastroenterol 153(6):1568-1580.e10","journal-title":"Promotes Hepatic Steatosis Gastroenterol"},{"issue":"7","key":"5004_CR30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s12094-021-02769-5","volume":"24","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2. Clin Transl Oncol 24(7):1311\u20131321","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"5004_CR31","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.21037\/tcr-22-1669","volume":"11","author":"Y Lin","year":"2022","unstructured":"Lin Y et al (2022) A narrative review on machine learning in diagnosis and prognosis prediction for tongue squamous cell carcinoma. Transl Cancer Res 11(12):4409\u20134415","journal-title":"Transl Cancer Res"},{"issue":"3","key":"5004_CR32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/jomfp.JOMFP_118_19","volume":"23","author":"K Mohideen","year":"2019","unstructured":"Mohideen K et al (2019) Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults. J Oral Maxillofac Pathol 23(3):450\u2013457","journal-title":"J Oral Maxillofac Pathol"},{"issue":"2","key":"5004_CR33","first-page":"617","volume":"43","author":"Z Hu","year":"2020","unstructured":"Hu Z, Zhao P, Xu H (2020) Hyperoside exhibits anticancer activity in non-small cell lung cancer cells with T790M mutations by upregulating FoxO1 via CCAT1. Oncol Rep 43(2):617\u2013624","journal-title":"Oncol Rep"},{"issue":"4","key":"5004_CR34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2019.04.112","volume":"513","author":"L Xing","year":"2019","unstructured":"Xing L et al (2019) Silencing FOXO1 attenuates dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 513(4):1019\u20131026","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5004_CR35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/15384047.2020.1727700","volume":"21","author":"X Li","year":"2020","unstructured":"Li X et al (2020) Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther 21(5):452\u2013462","journal-title":"Cancer Biol Ther"},{"key":"5004_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12935-018-0604-1","volume":"18","author":"Y Mu","year":"2018","unstructured":"Mu Y, Li N, Cui YL (2018) The lncRNA CCAT1 upregulates TGF\u03b2R1 via sponging miR-490-3p to promote TGF\u03b21-induced EMT of ovarian cancer cells. Cancer Cell Int 18:145","journal-title":"Cancer Cell Int"},{"issue":"8","key":"5004_CR37","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1007\/s10620-021-07187-9","volume":"67","author":"F Yang","year":"2022","unstructured":"Yang F et al (2022) LncRNA CCAT1 upregulates ATG5 to enhance autophagy and promote gastric cancer development by absorbing miR-140-3p. Dig Dis Sci 67(8):3725\u20133741","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5004_CR38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/15384101.2022.2109897","volume":"22","author":"H Wen","year":"2023","unstructured":"Wen H et al (2023) m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA. Cell Cycle 22(1):100\u2013116","journal-title":"Cell Cycle"},{"key":"5004_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091224","author":"Y Fan","year":"2022","unstructured":"Fan Y et al (2022) Role of WTAP in cancer: from mechanisms to the therapeutic potential. Biomolecules. https:\/\/doi.org\/10.3390\/biom12091224","journal-title":"Biomolecules"},{"issue":"2","key":"5004_CR40","first-page":"293","volume":"53","author":"F Liu","year":"2023","unstructured":"Liu F et al (2023) m6A methyltransferase, WTAP, promotes cancer progression in laryngeal squamous cell carcinoma by regulating PLAU stability. Ann Clin Lab Sci 53(2):293\u2013302","journal-title":"Ann Clin Lab Sci"},{"key":"5004_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biochi.2019.06.012","volume":"165","author":"H Yang","year":"2019","unstructured":"Yang H et al (2019) LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets. Biochimie 165:9\u201318","journal-title":"Biochimie"},{"issue":"3","key":"5004_CR42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H et al (2018) Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20(3):285\u2013295","journal-title":"Nat Cell Biol"},{"issue":"1","key":"5004_CR43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/nar\/gky1012","volume":"47","author":"S M\u00fcller","year":"2019","unstructured":"M\u00fcller S et al (2019) IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res 47(1):375\u2013390","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"5004_CR44","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1083\/jcb.201902048","volume":"218","author":"DG Nowak","year":"2019","unstructured":"Nowak DG et al (2019) The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. J Cell Biol 218(6):1943\u20131957","journal-title":"J Cell Biol"},{"issue":"25","key":"5004_CR45","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1523\/JNEUROSCI.3105-18.2019","volume":"39","author":"M Harterink","year":"2019","unstructured":"Harterink M et al (2019) TRIM46 organizes microtubule fasciculation in the axon initial segment. J Neurosci 39(25):4864\u20134873","journal-title":"J Neurosci"},{"key":"5004_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040609","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) Mmu-miR-1894\u20133p inhibits cell proliferation and migration of breast cancer cells by targeting Trim46. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17040609","journal-title":"Int J Mol Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05004-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:14:18Z","timestamp":1739888058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,19]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["5004"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05004-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,19]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics Committee of Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University) approved all animal experiments conducted in this study [2022\u2013160].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}